These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Salicylanilide derivatives block Mycobacterium tuberculosis through inhibition of isocitrate lyase and methionine aminopeptidase. Krátký M; Vinšová J; Novotná E; Mandíková J; Wsól V; Trejtnar F; Ulmann V; Stolaříková J; Fernandes S; Bhat S; Liu JO Tuberculosis (Edinb); 2012 Sep; 92(5):434-9. PubMed ID: 22765970 [TBL] [Abstract][Full Text] [Related]
7. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis. Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494 [TBL] [Abstract][Full Text] [Related]
8. Antimycobacterial assessment of Salicylanilide benzoates including multidrug-resistant tuberculosis strains. Krátký M; Vinšová J; Stolaříková J Molecules; 2012 Oct; 17(11):12812-20. PubMed ID: 23114617 [TBL] [Abstract][Full Text] [Related]
9. The oriented development of antituberculotics: salicylanilides. Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Kaustová J; Möllmann U; Dahse HM; Miko M Arch Pharm (Weinheim); 2006 Nov; 339(11):616-20. PubMed ID: 17048291 [TBL] [Abstract][Full Text] [Related]
10. In vitro biological evaluation of new antimycobacterial salicylanilide-tuftsin conjugates. Baranyai Z; Krátký M; Vosátka R; Szabó E; Senoner Z; Dávid S; Stolaříková J; Vinšová J; Bősze S Eur J Med Chem; 2017 Jun; 133():152-173. PubMed ID: 28384546 [TBL] [Abstract][Full Text] [Related]
12. Discovery of (3-Benzyl-5-hydroxyphenyl)carbamates as New Antitubercular Agents with Potent In Vitro and In Vivo Efficacy. Cheng YJ; Liu ZY; Liang HJ; Fang CT; Zhang NN; Zhang TY; Yan M Molecules; 2019 May; 24(10):. PubMed ID: 31137832 [TBL] [Abstract][Full Text] [Related]
13. New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action. Vosátka R; Krátký M; Švarcová M; Janoušek J; Stolaříková J; Madacki J; Huszár S; Mikušová K; Korduláková J; Trejtnar F; Vinšová J Eur J Med Chem; 2018 May; 151():824-835. PubMed ID: 29679902 [TBL] [Abstract][Full Text] [Related]
14. Salicylanilide N-monosubstituted carbamates: Synthesis and in vitro antimicrobial activity. Krátký M; Vinšová J Bioorg Med Chem; 2016 Mar; 24(6):1322-30. PubMed ID: 26879856 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates. Krátký M; Bősze S; Baranyai Z; Szabó I; Stolaříková J; Paraskevopoulos G; Vinšová J Bioorg Med Chem; 2015 Feb; 23(4):868-75. PubMed ID: 25593095 [TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of 2-(2-isonicotinoylhydrazineylidene)propanamides as InhA inhibitors with high antitubercular activity. Pflégr V; Horváth L; Stolaříková J; Pál A; Korduláková J; Bősze S; Vinšová J; Krátký M Eur J Med Chem; 2021 Nov; 223():113668. PubMed ID: 34198149 [TBL] [Abstract][Full Text] [Related]